KVUE

Kenvue Inc.
NYSECONSUMER DEFENSIVEHOUSEHOLD & PERSONAL PRODUCTS

Key Statistics

Market Cap
$36.32B
P/E Ratio
21.99
EPS
$0.86
Beta
0.45
52W High
$19.67
52W Low
$13.22
50-Day MA
$18.34
200-Day MA
$18.07
Dividend Yield
4.45%
Profit Margin
10.80%
Forward P/E
14.73
PEG Ratio
1.40

About Kenvue Inc.

Kenvue Inc. is a consumer health company globally.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$15.41B
Gross Profit (TTM)$9.00B
EBITDA$3.48B
Operating Margin19.40%
Return on Equity15.60%
Return on Assets6.99%
Revenue/Share (TTM)$8.04
Book Value$5.50
Price-to-Book3.22
Price-to-Sales (TTM)2.36
EV/Revenue2.69
EV/EBITDA12.89
Quarterly Earnings Growth (YoY)8.50%
Quarterly Revenue Growth (YoY)3.00%
Shares Outstanding$1.92B
Float$1.92B
% Insiders0.08%
% Institutions95.84%

Historical Volatility

HV 10-Day
18.48%
HV 20-Day
20.24%
HV 30-Day
21.21%
HV 60-Day
21.20%
HV Rank
47.2%

Volatility is currently contracting

Analyst Ratings

Consensus ($19.50 target)
1
Strong Buy
1
Buy
12
Hold

Latest News

Kimberly-Clark Announces Successful Consent Solicitations for Kenvue Notes and Amendment to Terms of Exchange Offers

DALLAS, Oct. 13, 2026 /PRNewswire/ -- Kimberly-Clark Corporation (NASDAQ: KMB) ("Kimberly-Clark") announced today that the requisite number of consents have been received to adopt certain proposed amendments (the "Amendments") with respect to all outstanding notes of Kenvue Inc. (NYSE: KVUE) ("Kenvue"). The results are based on (i) early tenders in the offers to exchange (each an "Exchange Offer" and, collectively, the "Exchange Offers") any and all outstanding notes (the "Kenvue Notes") issued by Kenvue for up to $7,000,000,000 aggregate principal amount of new notes to be issued by Kimberly-Clark (the "Kimberly-Clark Notes") and cash and (ii) related consent solicitations (each, a "Consent Solicitation" and, collectively, the "Consent Solicitations") being made by Kimberly-Clark on behalf of Kenvue to adopt the Amendments to the indenture (the "Kenvue Indenture") governing the Kenvue Notes.

PRNewsWire10/13/2026Neutral
Market Concentration Is Spooking Wall Street—I'm Buying Kenvue

While nervous investors obsess over a handful of tech giants propping up the whole market, one portfolio manager keeps funneling fresh cash into the brands sitting in every American medicine cabinet, and the reasoning might make you rethink your own

24/7 Wall Street10/8/2026Neutral
NWL or KVUE: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Consumer Products - Staples sector might want to consider either Newell Brands (NWL) or Kenvue (KVUE). But which of these two stocks is more attractive to value investors?

Zacks Investment Research10/6/2026Neutral
Kimberly-Clark Announces Planned Executive Transitions and Updates to Post-Closing Leadership Team

Russ Torres to Depart Kimberly-Clark for External CEO Role Carlos De Jesus to be Appointed as President, North America and Leonardo Curado to be Appointed as President, EMEA After Kenvue Acquisition DALLAS, Oct. 1, 2026 /PRNewswire/ -- Kimberly-Clark Corporation (NASDAQ: KMB) today announced planned executive transitions and updates to the future leadership team for the company upon completion of its pending acquisition of Kenvue Inc. (NYSE: KVUE), which is expected in the fourth quarter of 2026. Russ Torres, President and Chief Operating Officer of Kimberly-Clark, and Head of the Integration Management Office (IMO), will leave the company to assume an external CEO role.

PRNewsWire10/1/2026Neutral
Kimberly-Clark Corporation Announces Commencement of Exchange Offers and Consent Solicitations for Kenvue Notes

DALLAS, Sept. 28, 2026 /PRNewswire/ -- Kimberly-Clark Corporation (NASDAQ: KMB) ("Kimberly-Clark") announced today the commencement, in connection with its previously announced pending acquisition ("Acquisition") of Kenvue Inc. (NYSE: KVUE) ("Kenvue"), of an exchange offer (each an "Exchange Offer" and, collectively, the "Exchange Offers") for any and all outstanding notes (the "Kenvue Notes") issued by Kenvue for up to $7,000,000,000 aggregate principal amount of new notes to be issued by Kimberly-Clark (the "Kimberly-Clark Notes") and cash.

PRNewsWire9/28/2026Neutral
Better Dividend King to Buy and Hold: Johnson & Johnson or Kenvue?

Johnson & Johnson has raised its dividend for 64 straight years, but faces billions in talc-related litigation liabilities. Kenvue offers a higher yield of 4.71%, but its pending acquisition by Kimberly-Clark creates uncertainty about its dividend outlook.

The Motley Fool9/18/2026Positive

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on KVUE and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More CONSUMER DEFENSIVE Stocks

Data last updated: 10/17/2026